nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxcarbazepine—ALB—atherosclerosis	0.264	1	CbGaD
Oxcarbazepine—ALB—Rosuvastatin—atherosclerosis	0.0679	0.136	CbGbCtD
Oxcarbazepine—CYP3A5—Rosuvastatin—atherosclerosis	0.0546	0.109	CbGbCtD
Oxcarbazepine—CYP3A5—Simvastatin—atherosclerosis	0.0507	0.102	CbGbCtD
Oxcarbazepine—CYP3A5—Pravastatin—atherosclerosis	0.0496	0.0996	CbGbCtD
Oxcarbazepine—CYP3A5—Lovastatin—atherosclerosis	0.0496	0.0996	CbGbCtD
Oxcarbazepine—CYP2C19—Rosuvastatin—atherosclerosis	0.044	0.0883	CbGbCtD
Oxcarbazepine—CYP2C19—Simvastatin—atherosclerosis	0.0409	0.0821	CbGbCtD
Oxcarbazepine—CYP2C19—Lovastatin—atherosclerosis	0.04	0.0803	CbGbCtD
Oxcarbazepine—CYP3A4—Rosuvastatin—atherosclerosis	0.0213	0.0427	CbGbCtD
Oxcarbazepine—CYP3A4—Ezetimibe—atherosclerosis	0.0213	0.0427	CbGbCtD
Oxcarbazepine—CYP3A4—Simvastatin—atherosclerosis	0.0198	0.0397	CbGbCtD
Oxcarbazepine—CYP3A4—Lovastatin—atherosclerosis	0.0194	0.0388	CbGbCtD
Oxcarbazepine—CYP3A4—Pravastatin—atherosclerosis	0.0194	0.0388	CbGbCtD
Oxcarbazepine—Phenindamine—HRH1—atherosclerosis	0.000987	0.176	CrCbGaD
Oxcarbazepine—Methdilazine—HRH1—atherosclerosis	0.000667	0.119	CrCbGaD
Oxcarbazepine—Alimemazine—HRH1—atherosclerosis	0.000487	0.0866	CrCbGaD
Oxcarbazepine—Epinastine—HRH1—atherosclerosis	0.000445	0.0792	CrCbGaD
Oxcarbazepine—Tremor—Lovastatin—atherosclerosis	0.000316	0.00191	CcSEcCtD
Oxcarbazepine—Visual impairment—Pravastatin—atherosclerosis	0.000316	0.00191	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Lovastatin—atherosclerosis	0.000313	0.00189	CcSEcCtD
Oxcarbazepine—Eye disorder—Niacin—atherosclerosis	0.000311	0.00188	CcSEcCtD
Oxcarbazepine—Flatulence—Simvastatin—atherosclerosis	0.000311	0.00188	CcSEcCtD
Oxcarbazepine—Tinnitus—Niacin—atherosclerosis	0.000311	0.00188	CcSEcCtD
Oxcarbazepine—Erythema multiforme—Pravastatin—atherosclerosis	0.00031	0.00187	CcSEcCtD
Oxcarbazepine—Dysgeusia—Simvastatin—atherosclerosis	0.000309	0.00187	CcSEcCtD
Oxcarbazepine—Flushing—Niacin—atherosclerosis	0.000309	0.00187	CcSEcCtD
Oxcarbazepine—Angioedema—Lovastatin—atherosclerosis	0.000308	0.00187	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000307	0.00186	CcSEcCtD
Oxcarbazepine—Tinnitus—Pravastatin—atherosclerosis	0.000306	0.00185	CcSEcCtD
Oxcarbazepine—Malaise—Lovastatin—atherosclerosis	0.000304	0.00184	CcSEcCtD
Oxcarbazepine—Flushing—Pravastatin—atherosclerosis	0.000304	0.00184	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Pravastatin—atherosclerosis	0.000304	0.00184	CcSEcCtD
Oxcarbazepine—Vertigo—Lovastatin—atherosclerosis	0.000303	0.00183	CcSEcCtD
Oxcarbazepine—Angioedema—Ezetimibe—atherosclerosis	0.000303	0.00183	CcSEcCtD
Oxcarbazepine—Angiopathy—Niacin—atherosclerosis	0.000302	0.00183	CcSEcCtD
Oxcarbazepine—Leukopenia—Lovastatin—atherosclerosis	0.000302	0.00183	CcSEcCtD
Oxcarbazepine—Chills—Niacin—atherosclerosis	0.000299	0.00181	CcSEcCtD
Oxcarbazepine—Malaise—Ezetimibe—atherosclerosis	0.000299	0.00181	CcSEcCtD
Oxcarbazepine—Vision blurred—Simvastatin—atherosclerosis	0.000298	0.0018	CcSEcCtD
Oxcarbazepine—Arrhythmia—Niacin—atherosclerosis	0.000298	0.0018	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000296	0.00179	CcSEcCtD
Oxcarbazepine—Tremor—Simvastatin—atherosclerosis	0.000296	0.00179	CcSEcCtD
Oxcarbazepine—Alopecia—Niacin—atherosclerosis	0.000294	0.00178	CcSEcCtD
Oxcarbazepine—Chills—Pravastatin—atherosclerosis	0.000294	0.00178	CcSEcCtD
Oxcarbazepine—Insomnia—Rosuvastatin—atherosclerosis	0.000294	0.00178	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000293	0.00177	CcSEcCtD
Oxcarbazepine—Arrhythmia—Pravastatin—atherosclerosis	0.000293	0.00177	CcSEcCtD
Oxcarbazepine—Palpitations—Ezetimibe—atherosclerosis	0.000293	0.00177	CcSEcCtD
Oxcarbazepine—Malnutrition—Niacin—atherosclerosis	0.00029	0.00175	CcSEcCtD
Oxcarbazepine—Alopecia—Pravastatin—atherosclerosis	0.00029	0.00175	CcSEcCtD
Oxcarbazepine—Cough—Ezetimibe—atherosclerosis	0.000289	0.00175	CcSEcCtD
Oxcarbazepine—Angioedema—Simvastatin—atherosclerosis	0.000289	0.00174	CcSEcCtD
Oxcarbazepine—Chest pain—Lovastatin—atherosclerosis	0.000287	0.00174	CcSEcCtD
Oxcarbazepine—Arthralgia—Lovastatin—atherosclerosis	0.000287	0.00174	CcSEcCtD
Oxcarbazepine—Myalgia—Lovastatin—atherosclerosis	0.000287	0.00174	CcSEcCtD
Oxcarbazepine—Anxiety—Lovastatin—atherosclerosis	0.000286	0.00173	CcSEcCtD
Oxcarbazepine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000286	0.00173	CcSEcCtD
Oxcarbazepine—Hypertension—Ezetimibe—atherosclerosis	0.000286	0.00173	CcSEcCtD
Oxcarbazepine—Flatulence—Niacin—atherosclerosis	0.000286	0.00173	CcSEcCtD
Oxcarbazepine—Malaise—Simvastatin—atherosclerosis	0.000285	0.00172	CcSEcCtD
Oxcarbazepine—Tension—Niacin—atherosclerosis	0.000284	0.00172	CcSEcCtD
Oxcarbazepine—Discomfort—Lovastatin—atherosclerosis	0.000284	0.00172	CcSEcCtD
Oxcarbazepine—Vertigo—Simvastatin—atherosclerosis	0.000284	0.00172	CcSEcCtD
Oxcarbazepine—Leukopenia—Simvastatin—atherosclerosis	0.000283	0.00171	CcSEcCtD
Oxcarbazepine—Arthralgia—Ezetimibe—atherosclerosis	0.000282	0.0017	CcSEcCtD
Oxcarbazepine—Myalgia—Ezetimibe—atherosclerosis	0.000282	0.0017	CcSEcCtD
Oxcarbazepine—Chest pain—Ezetimibe—atherosclerosis	0.000282	0.0017	CcSEcCtD
Oxcarbazepine—Nervousness—Niacin—atherosclerosis	0.000282	0.0017	CcSEcCtD
Oxcarbazepine—Flatulence—Pravastatin—atherosclerosis	0.000281	0.0017	CcSEcCtD
Oxcarbazepine—Dry mouth—Lovastatin—atherosclerosis	0.000281	0.0017	CcSEcCtD
Oxcarbazepine—Tension—Pravastatin—atherosclerosis	0.00028	0.00169	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00028	0.00169	CcSEcCtD
Oxcarbazepine—Dysgeusia—Pravastatin—atherosclerosis	0.00028	0.00169	CcSEcCtD
Oxcarbazepine—Discomfort—Ezetimibe—atherosclerosis	0.000278	0.00168	CcSEcCtD
Oxcarbazepine—Pain—Rosuvastatin—atherosclerosis	0.000278	0.00168	CcSEcCtD
Oxcarbazepine—Constipation—Rosuvastatin—atherosclerosis	0.000278	0.00168	CcSEcCtD
Oxcarbazepine—Confusional state—Lovastatin—atherosclerosis	0.000278	0.00168	CcSEcCtD
Oxcarbazepine—Nervousness—Pravastatin—atherosclerosis	0.000277	0.00168	CcSEcCtD
Oxcarbazepine—Dry mouth—Ezetimibe—atherosclerosis	0.000276	0.00167	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000275	0.00167	CcSEcCtD
Oxcarbazepine—Infection—Lovastatin—atherosclerosis	0.000274	0.00166	CcSEcCtD
Oxcarbazepine—Vision blurred—Niacin—atherosclerosis	0.000273	0.00165	CcSEcCtD
Oxcarbazepine—Confusional state—Ezetimibe—atherosclerosis	0.000272	0.00165	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00027	0.00163	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Lovastatin—atherosclerosis	0.00027	0.00163	CcSEcCtD
Oxcarbazepine—Vision blurred—Pravastatin—atherosclerosis	0.000269	0.00163	CcSEcCtD
Oxcarbazepine—Chest pain—Simvastatin—atherosclerosis	0.000269	0.00163	CcSEcCtD
Oxcarbazepine—Myalgia—Simvastatin—atherosclerosis	0.000269	0.00163	CcSEcCtD
Oxcarbazepine—Arthralgia—Simvastatin—atherosclerosis	0.000269	0.00163	CcSEcCtD
Oxcarbazepine—Infection—Ezetimibe—atherosclerosis	0.000268	0.00162	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000268	0.00162	CcSEcCtD
Oxcarbazepine—Anxiety—Simvastatin—atherosclerosis	0.000268	0.00162	CcSEcCtD
Oxcarbazepine—Tremor—Pravastatin—atherosclerosis	0.000267	0.00162	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000266	0.00161	CcSEcCtD
Oxcarbazepine—Discomfort—Simvastatin—atherosclerosis	0.000266	0.00161	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000265	0.0016	CcSEcCtD
Oxcarbazepine—Angioedema—Niacin—atherosclerosis	0.000265	0.0016	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000265	0.0016	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000265	0.0016	CcSEcCtD
Oxcarbazepine—Anorexia—Lovastatin—atherosclerosis	0.000263	0.00159	CcSEcCtD
Oxcarbazepine—Skin disorder—Ezetimibe—atherosclerosis	0.000262	0.00159	CcSEcCtD
Oxcarbazepine—Angioedema—Pravastatin—atherosclerosis	0.000261	0.00158	CcSEcCtD
Oxcarbazepine—Vertigo—Niacin—atherosclerosis	0.00026	0.00158	CcSEcCtD
Oxcarbazepine—Syncope—Niacin—atherosclerosis	0.00026	0.00157	CcSEcCtD
Oxcarbazepine—Confusional state—Simvastatin—atherosclerosis	0.00026	0.00157	CcSEcCtD
Oxcarbazepine—Leukopenia—Niacin—atherosclerosis	0.00026	0.00157	CcSEcCtD
Oxcarbazepine—Urticaria—Rosuvastatin—atherosclerosis	0.000258	0.00156	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000258	0.00156	CcSEcCtD
Oxcarbazepine—Mianserin—HRH1—atherosclerosis	0.000257	0.0458	CrCbGaD
Oxcarbazepine—Malaise—Pravastatin—atherosclerosis	0.000257	0.00156	CcSEcCtD
Oxcarbazepine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000257	0.00155	CcSEcCtD
Oxcarbazepine—Vertigo—Pravastatin—atherosclerosis	0.000256	0.00155	CcSEcCtD
Oxcarbazepine—Palpitations—Niacin—atherosclerosis	0.000256	0.00155	CcSEcCtD
Oxcarbazepine—Infection—Simvastatin—atherosclerosis	0.000256	0.00155	CcSEcCtD
Oxcarbazepine—Leukopenia—Pravastatin—atherosclerosis	0.000256	0.00155	CcSEcCtD
Oxcarbazepine—Loss of consciousness—Niacin—atherosclerosis	0.000255	0.00154	CcSEcCtD
Oxcarbazepine—Cough—Niacin—atherosclerosis	0.000253	0.00153	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000252	0.00153	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000251	0.00152	CcSEcCtD
Oxcarbazepine—Insomnia—Lovastatin—atherosclerosis	0.000249	0.00151	CcSEcCtD
Oxcarbazepine—Cough—Pravastatin—atherosclerosis	0.000249	0.00151	CcSEcCtD
Oxcarbazepine—Arthralgia—Niacin—atherosclerosis	0.000247	0.00149	CcSEcCtD
Oxcarbazepine—Myalgia—Niacin—atherosclerosis	0.000247	0.00149	CcSEcCtD
Oxcarbazepine—Hypertension—Pravastatin—atherosclerosis	0.000246	0.00149	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000246	0.00149	CcSEcCtD
Oxcarbazepine—Anorexia—Simvastatin—atherosclerosis	0.000246	0.00149	CcSEcCtD
Oxcarbazepine—Dyspnoea—Lovastatin—atherosclerosis	0.000246	0.00149	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000245	0.00148	CcSEcCtD
Oxcarbazepine—Insomnia—Ezetimibe—atherosclerosis	0.000244	0.00148	CcSEcCtD
Oxcarbazepine—Myalgia—Pravastatin—atherosclerosis	0.000243	0.00147	CcSEcCtD
Oxcarbazepine—Chest pain—Pravastatin—atherosclerosis	0.000243	0.00147	CcSEcCtD
Oxcarbazepine—Arthralgia—Pravastatin—atherosclerosis	0.000243	0.00147	CcSEcCtD
Oxcarbazepine—Dyspepsia—Lovastatin—atherosclerosis	0.000243	0.00147	CcSEcCtD
Oxcarbazepine—Anxiety—Pravastatin—atherosclerosis	0.000242	0.00146	CcSEcCtD
Oxcarbazepine—Dry mouth—Niacin—atherosclerosis	0.000241	0.00146	CcSEcCtD
Oxcarbazepine—Dyspnoea—Ezetimibe—atherosclerosis	0.000241	0.00146	CcSEcCtD
Oxcarbazepine—Discomfort—Pravastatin—atherosclerosis	0.00024	0.00145	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00024	0.00145	CcSEcCtD
Oxcarbazepine—Decreased appetite—Lovastatin—atherosclerosis	0.000239	0.00145	CcSEcCtD
Oxcarbazepine—Dyspepsia—Ezetimibe—atherosclerosis	0.000238	0.00144	CcSEcCtD
Oxcarbazepine—Fatigue—Lovastatin—atherosclerosis	0.000238	0.00144	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Niacin—atherosclerosis	0.000237	0.00143	CcSEcCtD
Oxcarbazepine—Pain—Lovastatin—atherosclerosis	0.000236	0.00142	CcSEcCtD
Oxcarbazepine—Constipation—Lovastatin—atherosclerosis	0.000236	0.00142	CcSEcCtD
Oxcarbazepine—Confusional state—Pravastatin—atherosclerosis	0.000235	0.00142	CcSEcCtD
Oxcarbazepine—Decreased appetite—Ezetimibe—atherosclerosis	0.000235	0.00142	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000235	0.00142	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000233	0.00141	CcSEcCtD
Oxcarbazepine—Asthenia—Rosuvastatin—atherosclerosis	0.000233	0.00141	CcSEcCtD
Oxcarbazepine—Insomnia—Simvastatin—atherosclerosis	0.000233	0.00141	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000233	0.00141	CcSEcCtD
Oxcarbazepine—Fatigue—Ezetimibe—atherosclerosis	0.000233	0.00141	CcSEcCtD
Oxcarbazepine—Shock—Niacin—atherosclerosis	0.000233	0.00141	CcSEcCtD
Oxcarbazepine—Infection—Pravastatin—atherosclerosis	0.000231	0.0014	CcSEcCtD
Oxcarbazepine—Constipation—Ezetimibe—atherosclerosis	0.000231	0.0014	CcSEcCtD
Oxcarbazepine—Pain—Ezetimibe—atherosclerosis	0.000231	0.0014	CcSEcCtD
Oxcarbazepine—Tachycardia—Niacin—atherosclerosis	0.000231	0.0014	CcSEcCtD
Oxcarbazepine—Nortriptyline—HRH1—atherosclerosis	0.00023	0.041	CrCbGaD
Oxcarbazepine—Pruritus—Rosuvastatin—atherosclerosis	0.00023	0.00139	CcSEcCtD
Oxcarbazepine—Skin disorder—Niacin—atherosclerosis	0.00023	0.00139	CcSEcCtD
Oxcarbazepine—Dyspnoea—Simvastatin—atherosclerosis	0.00023	0.00139	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Niacin—atherosclerosis	0.000229	0.00138	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000228	0.00138	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Lovastatin—atherosclerosis	0.000227	0.00137	CcSEcCtD
Oxcarbazepine—Dyspepsia—Simvastatin—atherosclerosis	0.000227	0.00137	CcSEcCtD
Oxcarbazepine—Anorexia—Niacin—atherosclerosis	0.000226	0.00136	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000225	0.00136	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000225	0.00136	CcSEcCtD
Oxcarbazepine—Decreased appetite—Simvastatin—atherosclerosis	0.000224	0.00135	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000223	0.00135	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000222	0.00135	CcSEcCtD
Oxcarbazepine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000222	0.00135	CcSEcCtD
Oxcarbazepine—Fatigue—Simvastatin—atherosclerosis	0.000222	0.00134	CcSEcCtD
Oxcarbazepine—Anorexia—Pravastatin—atherosclerosis	0.000222	0.00134	CcSEcCtD
Oxcarbazepine—Hypotension—Niacin—atherosclerosis	0.000221	0.00134	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000221	0.00134	CcSEcCtD
Oxcarbazepine—Constipation—Simvastatin—atherosclerosis	0.00022	0.00133	CcSEcCtD
Oxcarbazepine—Pain—Simvastatin—atherosclerosis	0.00022	0.00133	CcSEcCtD
Oxcarbazepine—Urticaria—Lovastatin—atherosclerosis	0.000219	0.00132	CcSEcCtD
Oxcarbazepine—Abdominal pain—Lovastatin—atherosclerosis	0.000218	0.00132	CcSEcCtD
Oxcarbazepine—Body temperature increased—Lovastatin—atherosclerosis	0.000218	0.00132	CcSEcCtD
Oxcarbazepine—Trimipramine—HRH1—atherosclerosis	0.000217	0.0386	CrCbGaD
Oxcarbazepine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000216	0.0013	CcSEcCtD
Oxcarbazepine—Dizziness—Rosuvastatin—atherosclerosis	0.000215	0.0013	CcSEcCtD
Oxcarbazepine—Urticaria—Ezetimibe—atherosclerosis	0.000215	0.0013	CcSEcCtD
Oxcarbazepine—Insomnia—Niacin—atherosclerosis	0.000214	0.00129	CcSEcCtD
Oxcarbazepine—Body temperature increased—Ezetimibe—atherosclerosis	0.000214	0.00129	CcSEcCtD
Oxcarbazepine—Abdominal pain—Ezetimibe—atherosclerosis	0.000214	0.00129	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Simvastatin—atherosclerosis	0.000212	0.00128	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000212	0.00128	CcSEcCtD
Oxcarbazepine—Dyspnoea—Niacin—atherosclerosis	0.000211	0.00128	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000211	0.00127	CcSEcCtD
Oxcarbazepine—Insomnia—Pravastatin—atherosclerosis	0.000211	0.00127	CcSEcCtD
Oxcarbazepine—Somnolence—Niacin—atherosclerosis	0.00021	0.00127	CcSEcCtD
Oxcarbazepine—Promethazine—HRH1—atherosclerosis	0.000209	0.0371	CrCbGaD
Oxcarbazepine—Dyspepsia—Niacin—atherosclerosis	0.000208	0.00126	CcSEcCtD
Oxcarbazepine—Dyspnoea—Pravastatin—atherosclerosis	0.000208	0.00126	CcSEcCtD
Oxcarbazepine—Doxepin—HRH1—atherosclerosis	0.000207	0.0367	CrCbGaD
Oxcarbazepine—Decreased appetite—Niacin—atherosclerosis	0.000206	0.00124	CcSEcCtD
Oxcarbazepine—Dyspepsia—Pravastatin—atherosclerosis	0.000205	0.00124	CcSEcCtD
Oxcarbazepine—Rash—Rosuvastatin—atherosclerosis	0.000205	0.00124	CcSEcCtD
Oxcarbazepine—Dermatitis—Rosuvastatin—atherosclerosis	0.000205	0.00124	CcSEcCtD
Oxcarbazepine—Urticaria—Simvastatin—atherosclerosis	0.000205	0.00124	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000204	0.00124	CcSEcCtD
Oxcarbazepine—Body temperature increased—Simvastatin—atherosclerosis	0.000204	0.00123	CcSEcCtD
Oxcarbazepine—Abdominal pain—Simvastatin—atherosclerosis	0.000204	0.00123	CcSEcCtD
Oxcarbazepine—Headache—Rosuvastatin—atherosclerosis	0.000204	0.00123	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Lovastatin—atherosclerosis	0.000203	0.00123	CcSEcCtD
Oxcarbazepine—Decreased appetite—Pravastatin—atherosclerosis	0.000203	0.00122	CcSEcCtD
Oxcarbazepine—Pain—Niacin—atherosclerosis	0.000202	0.00122	CcSEcCtD
Oxcarbazepine—Fatigue—Pravastatin—atherosclerosis	0.000201	0.00121	CcSEcCtD
Oxcarbazepine—Constipation—Pravastatin—atherosclerosis	0.000199	0.0012	CcSEcCtD
Oxcarbazepine—Pain—Pravastatin—atherosclerosis	0.000199	0.0012	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000199	0.0012	CcSEcCtD
Oxcarbazepine—Asthenia—Lovastatin—atherosclerosis	0.000198	0.0012	CcSEcCtD
Oxcarbazepine—Pruritus—Lovastatin—atherosclerosis	0.000195	0.00118	CcSEcCtD
Oxcarbazepine—Asthenia—Ezetimibe—atherosclerosis	0.000194	0.00117	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Niacin—atherosclerosis	0.000193	0.00117	CcSEcCtD
Oxcarbazepine—Nausea—Rosuvastatin—atherosclerosis	0.000193	0.00117	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Pravastatin—atherosclerosis	0.000192	0.00116	CcSEcCtD
Oxcarbazepine—Pruritus—Ezetimibe—atherosclerosis	0.000191	0.00116	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000191	0.00115	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Simvastatin—atherosclerosis	0.00019	0.00115	CcSEcCtD
Oxcarbazepine—Desipramine—HRH1—atherosclerosis	0.000189	0.0337	CrCbGaD
Oxcarbazepine—Diarrhoea—Lovastatin—atherosclerosis	0.000188	0.00114	CcSEcCtD
Oxcarbazepine—Urticaria—Niacin—atherosclerosis	0.000188	0.00114	CcSEcCtD
Oxcarbazepine—Body temperature increased—Niacin—atherosclerosis	0.000187	0.00113	CcSEcCtD
Oxcarbazepine—Abdominal pain—Niacin—atherosclerosis	0.000187	0.00113	CcSEcCtD
Oxcarbazepine—Urticaria—Pravastatin—atherosclerosis	0.000185	0.00112	CcSEcCtD
Oxcarbazepine—Asthenia—Simvastatin—atherosclerosis	0.000185	0.00112	CcSEcCtD
Oxcarbazepine—Diarrhoea—Ezetimibe—atherosclerosis	0.000185	0.00112	CcSEcCtD
Oxcarbazepine—Nepafenac—PTGS2—atherosclerosis	0.000184	0.0328	CrCbGaD
Oxcarbazepine—Body temperature increased—Pravastatin—atherosclerosis	0.000184	0.00111	CcSEcCtD
Oxcarbazepine—Abdominal pain—Pravastatin—atherosclerosis	0.000184	0.00111	CcSEcCtD
Oxcarbazepine—Promazine—HRH1—atherosclerosis	0.000184	0.0327	CrCbGaD
Oxcarbazepine—Pruritus—Simvastatin—atherosclerosis	0.000182	0.0011	CcSEcCtD
Oxcarbazepine—Dizziness—Lovastatin—atherosclerosis	0.000182	0.0011	CcSEcCtD
Oxcarbazepine—Magnesium salicylate—PTGS2—atherosclerosis	0.00018	0.0321	CrCbGaD
Oxcarbazepine—Dizziness—Ezetimibe—atherosclerosis	0.000179	0.00108	CcSEcCtD
Oxcarbazepine—Diarrhoea—Simvastatin—atherosclerosis	0.000176	0.00107	CcSEcCtD
Oxcarbazepine—Vomiting—Lovastatin—atherosclerosis	0.000175	0.00106	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Niacin—atherosclerosis	0.000174	0.00105	CcSEcCtD
Oxcarbazepine—Rash—Lovastatin—atherosclerosis	0.000174	0.00105	CcSEcCtD
Oxcarbazepine—Dermatitis—Lovastatin—atherosclerosis	0.000174	0.00105	CcSEcCtD
Oxcarbazepine—Piroxicam—PTGS2—atherosclerosis	0.000173	0.0308	CrCbGaD
Oxcarbazepine—Headache—Lovastatin—atherosclerosis	0.000173	0.00104	CcSEcCtD
Oxcarbazepine—Vomiting—Ezetimibe—atherosclerosis	0.000172	0.00104	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Pravastatin—atherosclerosis	0.000172	0.00104	CcSEcCtD
Oxcarbazepine—Dizziness—Simvastatin—atherosclerosis	0.00017	0.00103	CcSEcCtD
Oxcarbazepine—Rash—Ezetimibe—atherosclerosis	0.00017	0.00103	CcSEcCtD
Oxcarbazepine—Dermatitis—Ezetimibe—atherosclerosis	0.00017	0.00103	CcSEcCtD
Oxcarbazepine—Asthenia—Niacin—atherosclerosis	0.00017	0.00103	CcSEcCtD
Oxcarbazepine—Headache—Ezetimibe—atherosclerosis	0.000169	0.00102	CcSEcCtD
Oxcarbazepine—Pruritus—Niacin—atherosclerosis	0.000167	0.00101	CcSEcCtD
Oxcarbazepine—Asthenia—Pravastatin—atherosclerosis	0.000167	0.00101	CcSEcCtD
Oxcarbazepine—Pruritus—Pravastatin—atherosclerosis	0.000165	0.000997	CcSEcCtD
Oxcarbazepine—Vomiting—Simvastatin—atherosclerosis	0.000164	0.000991	CcSEcCtD
Oxcarbazepine—Nausea—Lovastatin—atherosclerosis	0.000164	0.00099	CcSEcCtD
Oxcarbazepine—Rash—Simvastatin—atherosclerosis	0.000162	0.000983	CcSEcCtD
Oxcarbazepine—Dermatitis—Simvastatin—atherosclerosis	0.000162	0.000982	CcSEcCtD
Oxcarbazepine—Diarrhoea—Niacin—atherosclerosis	0.000162	0.000979	CcSEcCtD
Oxcarbazepine—Headache—Simvastatin—atherosclerosis	0.000161	0.000976	CcSEcCtD
Oxcarbazepine—Imipramine—HRH1—atherosclerosis	0.000161	0.0286	CrCbGaD
Oxcarbazepine—Magnesium salicylate—ALB—atherosclerosis	0.000161	0.0286	CrCbGaD
Oxcarbazepine—Nausea—Ezetimibe—atherosclerosis	0.000161	0.000971	CcSEcCtD
Oxcarbazepine—Amitriptyline—HRH1—atherosclerosis	0.00016	0.0284	CrCbGaD
Oxcarbazepine—Diarrhoea—Pravastatin—atherosclerosis	0.000159	0.000964	CcSEcCtD
Oxcarbazepine—Dizziness—Niacin—atherosclerosis	0.000156	0.000946	CcSEcCtD
Oxcarbazepine—Dizziness—Pravastatin—atherosclerosis	0.000154	0.000932	CcSEcCtD
Oxcarbazepine—Piroxicam—ALB—atherosclerosis	0.000154	0.0274	CrCbGaD
Oxcarbazepine—Salsalate—PTGS2—atherosclerosis	0.000153	0.0273	CrCbGaD
Oxcarbazepine—Nausea—Simvastatin—atherosclerosis	0.000153	0.000926	CcSEcCtD
Oxcarbazepine—Vomiting—Niacin—atherosclerosis	0.00015	0.00091	CcSEcCtD
Oxcarbazepine—Rash—Niacin—atherosclerosis	0.000149	0.000902	CcSEcCtD
Oxcarbazepine—Dermatitis—Niacin—atherosclerosis	0.000149	0.000901	CcSEcCtD
Oxcarbazepine—Headache—Niacin—atherosclerosis	0.000148	0.000896	CcSEcCtD
Oxcarbazepine—Vomiting—Pravastatin—atherosclerosis	0.000148	0.000896	CcSEcCtD
Oxcarbazepine—Rash—Pravastatin—atherosclerosis	0.000147	0.000888	CcSEcCtD
Oxcarbazepine—Dermatitis—Pravastatin—atherosclerosis	0.000147	0.000888	CcSEcCtD
Oxcarbazepine—Headache—Pravastatin—atherosclerosis	0.000146	0.000883	CcSEcCtD
Oxcarbazepine—Nausea—Niacin—atherosclerosis	0.000141	0.00085	CcSEcCtD
Oxcarbazepine—Nausea—Pravastatin—atherosclerosis	0.000138	0.000837	CcSEcCtD
Oxcarbazepine—Warfarin—ALB—atherosclerosis	8.63e-05	0.0154	CrCbGaD
Oxcarbazepine—Nortriptyline—ALB—atherosclerosis	5.31e-05	0.00946	CrCbGaD
Oxcarbazepine—Diazepam—ALB—atherosclerosis	4.02e-05	0.00715	CrCbGaD
Oxcarbazepine—Amitriptyline—ALB—atherosclerosis	3.69e-05	0.00656	CrCbGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	3.01e-05	0.000453	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	3e-05	0.000451	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ABCG1—atherosclerosis	2.99e-05	0.000449	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—SERPINE1—atherosclerosis	2.97e-05	0.000447	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—IL6—atherosclerosis	2.96e-05	0.000445	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ABCG8—atherosclerosis	2.92e-05	0.000439	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—LTA4H—atherosclerosis	2.92e-05	0.000439	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	2.88e-05	0.000434	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—KNG1—atherosclerosis	2.85e-05	0.000429	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—VEGFA—atherosclerosis	2.85e-05	0.000429	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PLAUR—atherosclerosis	2.83e-05	0.000425	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—STAT3—atherosclerosis	2.82e-05	0.000425	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—PLAT—atherosclerosis	2.81e-05	0.000423	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—FABP4—atherosclerosis	2.81e-05	0.000422	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—LCAT—atherosclerosis	2.81e-05	0.000422	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—IL6—atherosclerosis	2.76e-05	0.000416	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PLG—atherosclerosis	2.76e-05	0.000415	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—APOA4—atherosclerosis	2.76e-05	0.000415	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	2.72e-05	0.00041	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP7A1—atherosclerosis	2.71e-05	0.000407	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.7e-05	0.000407	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—MAPK3—atherosclerosis	2.7e-05	0.000406	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—SOD1—atherosclerosis	2.65e-05	0.000398	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—TGFB1—atherosclerosis	2.62e-05	0.000394	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ABCG1—atherosclerosis	2.57e-05	0.000387	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—IGF2—atherosclerosis	2.51e-05	0.000378	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP27A1—atherosclerosis	2.5e-05	0.000377	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—TNF—atherosclerosis	2.44e-05	0.000367	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—APOB—atherosclerosis	2.44e-05	0.000367	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.43e-05	0.000365	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—FABP4—atherosclerosis	2.42e-05	0.000364	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—LCAT—atherosclerosis	2.42e-05	0.000364	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—PLG—atherosclerosis	2.39e-05	0.00036	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—APOA4—atherosclerosis	2.37e-05	0.000357	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ALOX5AP—atherosclerosis	2.37e-05	0.000357	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ALOX15—atherosclerosis	2.37e-05	0.000357	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PLA2G2A—atherosclerosis	2.37e-05	0.000357	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—APOA2—atherosclerosis	2.37e-05	0.000357	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ABCG5—atherosclerosis	2.34e-05	0.000353	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP7A1—atherosclerosis	2.33e-05	0.000351	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ABCG1—atherosclerosis	2.31e-05	0.000347	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PRKCG—atherosclerosis	2.27e-05	0.000341	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—LPA—atherosclerosis	2.26e-05	0.000341	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.22e-05	0.000334	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—CD36—atherosclerosis	2.21e-05	0.000333	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.21e-05	0.000332	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—BGN—atherosclerosis	2.19e-05	0.00033	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—FABP4—atherosclerosis	2.17e-05	0.000327	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—LCAT—atherosclerosis	2.17e-05	0.000327	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—APOA5—atherosclerosis	2.17e-05	0.000326	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP27A1—atherosclerosis	2.16e-05	0.000324	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	2.15e-05	0.000324	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—APOA4—atherosclerosis	2.13e-05	0.000321	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.12e-05	0.000319	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—APOB—atherosclerosis	2.11e-05	0.000318	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP7A1—atherosclerosis	2.09e-05	0.000315	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PLA2G1B—atherosclerosis	2.09e-05	0.000314	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.07e-05	0.000311	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—VEGFA—atherosclerosis	2.05e-05	0.000308	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PLA2G2A—atherosclerosis	2.04e-05	0.000307	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—APOA2—atherosclerosis	2.04e-05	0.000307	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ALOX5AP—atherosclerosis	2.04e-05	0.000307	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ALOX15—atherosclerosis	2.04e-05	0.000307	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PDGFB—atherosclerosis	2.04e-05	0.000307	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PLTP—atherosclerosis	2.03e-05	0.000305	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—MMP1—atherosclerosis	2.02e-05	0.000304	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ABCG5—atherosclerosis	2.02e-05	0.000304	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ALOX5—atherosclerosis	2.02e-05	0.000303	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.02e-05	0.000303	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.99e-05	0.0003	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—IL6—atherosclerosis	1.97e-05	0.000297	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—LPA—atherosclerosis	1.95e-05	0.000293	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—CAV1—atherosclerosis	1.94e-05	0.000291	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	1.94e-05	0.000291	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP27A1—atherosclerosis	1.93e-05	0.000291	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—APOA1—atherosclerosis	1.93e-05	0.000291	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.9e-05	0.000287	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—BGN—atherosclerosis	1.89e-05	0.000284	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	1.88e-05	0.000282	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.87e-05	0.000282	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—APOA5—atherosclerosis	1.87e-05	0.000281	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.86e-05	0.00028	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—F2—atherosclerosis	1.84e-05	0.000277	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ALOX15—atherosclerosis	1.83e-05	0.000276	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ALOX5AP—atherosclerosis	1.83e-05	0.000276	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—APOA2—atherosclerosis	1.83e-05	0.000276	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PLA2G2A—atherosclerosis	1.83e-05	0.000276	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—NOS2—atherosclerosis	1.82e-05	0.000274	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—AKT1—atherosclerosis	1.82e-05	0.000274	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.82e-05	0.000273	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ABCG5—atherosclerosis	1.81e-05	0.000273	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.81e-05	0.000272	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—NAMPT—atherosclerosis	1.81e-05	0.000272	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PLA2G1B—atherosclerosis	1.8e-05	0.000271	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—LIPC—atherosclerosis	1.8e-05	0.000271	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—APOC3—atherosclerosis	1.79e-05	0.000269	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.78e-05	0.000268	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.78e-05	0.000268	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—LDLR—atherosclerosis	1.78e-05	0.000267	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PIK3CG—atherosclerosis	1.76e-05	0.000265	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.76e-05	0.000265	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.76e-05	0.000265	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.76e-05	0.000264	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.76e-05	0.000264	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—LPA—atherosclerosis	1.75e-05	0.000263	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ALOX5—atherosclerosis	1.74e-05	0.000261	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CETP—atherosclerosis	1.73e-05	0.000261	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—BGN—atherosclerosis	1.69e-05	0.000255	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.68e-05	0.000253	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—APOA5—atherosclerosis	1.68e-05	0.000252	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.67e-05	0.000252	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—SCARB1—atherosclerosis	1.66e-05	0.00025	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.63e-05	0.000245	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	1.61e-05	0.000243	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—IGF1—atherosclerosis	1.61e-05	0.000243	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.61e-05	0.000241	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.6e-05	0.00024	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.58e-05	0.000238	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.58e-05	0.000237	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—HMGCR—atherosclerosis	1.57e-05	0.000236	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ALOX5—atherosclerosis	1.56e-05	0.000235	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NAMPT—atherosclerosis	1.56e-05	0.000234	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.55e-05	0.000233	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—LIPC—atherosclerosis	1.55e-05	0.000233	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—APOC3—atherosclerosis	1.54e-05	0.000232	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—SERPINE1—atherosclerosis	1.53e-05	0.000231	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—LDLR—atherosclerosis	1.53e-05	0.00023	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CETP—atherosclerosis	1.49e-05	0.000225	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—NOS3—atherosclerosis	1.46e-05	0.00022	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.44e-05	0.000217	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—SCARB1—atherosclerosis	1.43e-05	0.000215	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.4e-05	0.00021	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ABCA1—atherosclerosis	1.4e-05	0.00021	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.39e-05	0.000209	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—LIPC—atherosclerosis	1.39e-05	0.000209	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.39e-05	0.000209	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—APOC3—atherosclerosis	1.38e-05	0.000208	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—LDLR—atherosclerosis	1.37e-05	0.000207	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—HMGCR—atherosclerosis	1.35e-05	0.000203	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CETP—atherosclerosis	1.34e-05	0.000202	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—FABP4—atherosclerosis	1.31e-05	0.000196	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—LCAT—atherosclerosis	1.31e-05	0.000196	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	1.31e-05	0.000196	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.28e-05	0.000193	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—APOA4—atherosclerosis	1.28e-05	0.000193	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.26e-05	0.000189	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.25e-05	0.000188	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.22e-05	0.000183	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.21e-05	0.000182	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ABCA1—atherosclerosis	1.2e-05	0.000181	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—HMOX1—atherosclerosis	1.2e-05	0.00018	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.16e-05	0.000175	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—APOB—atherosclerosis	1.15e-05	0.000173	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTM1—atherosclerosis	1.12e-05	0.000168	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.1e-05	0.000166	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.1e-05	0.000166	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—APOA2—atherosclerosis	1.1e-05	0.000166	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.1e-05	0.000166	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—LPL—atherosclerosis	1.1e-05	0.000165	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.09e-05	0.000165	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.09e-05	0.000164	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ABCA1—atherosclerosis	1.08e-05	0.000163	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GPX1—atherosclerosis	1.07e-05	0.000161	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—VEGFA—atherosclerosis	1.05e-05	0.000159	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—LPA—atherosclerosis	1.05e-05	0.000158	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CD36—atherosclerosis	1.04e-05	0.000157	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—HMOX1—atherosclerosis	1.03e-05	0.000155	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—BGN—atherosclerosis	1.02e-05	0.000153	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—APOA5—atherosclerosis	1.01e-05	0.000152	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—MAPK3—atherosclerosis	9.97e-06	0.00015	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—APOB—atherosclerosis	9.9e-06	0.000149	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—MTHFR—atherosclerosis	9.88e-06	0.000149	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	9.71e-06	0.000146	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PPARA—atherosclerosis	9.69e-06	0.000146	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—TGFB1—atherosclerosis	9.68e-06	0.000146	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTM1—atherosclerosis	9.63e-06	0.000145	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—LPL—atherosclerosis	9.45e-06	0.000142	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—AGT—atherosclerosis	9.39e-06	0.000141	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ALOX5—atherosclerosis	9.38e-06	0.000141	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—HMOX1—atherosclerosis	9.27e-06	0.00014	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GPX1—atherosclerosis	9.22e-06	0.000139	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—APOE—atherosclerosis	9.2e-06	0.000138	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CAV1—atherosclerosis	9.11e-06	0.000137	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—APOA1—atherosclerosis	9.09e-06	0.000137	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CD36—atherosclerosis	8.98e-06	0.000135	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—APOB—atherosclerosis	8.88e-06	0.000134	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTM1—atherosclerosis	8.64e-06	0.00013	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—MTHFR—atherosclerosis	8.51e-06	0.000128	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—LPL—atherosclerosis	8.48e-06	0.000128	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NAMPT—atherosclerosis	8.41e-06	0.000127	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—LIPC—atherosclerosis	8.36e-06	0.000126	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PPARA—atherosclerosis	8.35e-06	0.000126	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—APOC3—atherosclerosis	8.31e-06	0.000125	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PIK3CG—atherosclerosis	8.3e-06	0.000125	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GPX1—atherosclerosis	8.28e-06	0.000125	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—LDLR—atherosclerosis	8.26e-06	0.000124	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—AGT—atherosclerosis	8.08e-06	0.000122	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CETP—atherosclerosis	8.06e-06	0.000121	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CD36—atherosclerosis	8.06e-06	0.000121	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PPARG—atherosclerosis	8.01e-06	0.000121	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—APOE—atherosclerosis	7.92e-06	0.000119	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—INS—atherosclerosis	7.86e-06	0.000118	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CAV1—atherosclerosis	7.85e-06	0.000118	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—APOA1—atherosclerosis	7.83e-06	0.000118	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—SCARB1—atherosclerosis	7.72e-06	0.000116	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—MTHFR—atherosclerosis	7.64e-06	0.000115	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PPARA—atherosclerosis	7.49e-06	0.000113	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—HMGCR—atherosclerosis	7.29e-06	0.00011	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—AGT—atherosclerosis	7.26e-06	0.000109	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ALB—atherosclerosis	7.2e-06	0.000108	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PIK3CG—atherosclerosis	7.15e-06	0.000108	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—APOE—atherosclerosis	7.11e-06	0.000107	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CAV1—atherosclerosis	7.05e-06	0.000106	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—APOA1—atherosclerosis	7.03e-06	0.000106	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PPARG—atherosclerosis	6.9e-06	0.000104	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—NOS3—atherosclerosis	6.89e-06	0.000104	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—INS—atherosclerosis	6.77e-06	0.000102	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—AKT1—atherosclerosis	6.73e-06	0.000101	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ABCA1—atherosclerosis	6.5e-06	9.78e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	6.42e-06	9.65e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PTGS2—atherosclerosis	6.3e-06	9.48e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PPARG—atherosclerosis	6.19e-06	9.32e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—INS—atherosclerosis	6.07e-06	9.14e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NOS3—atherosclerosis	5.93e-06	8.93e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—HMOX1—atherosclerosis	5.58e-06	8.39e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ALB—atherosclerosis	5.57e-06	8.38e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PTGS2—atherosclerosis	5.43e-06	8.17e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—APOB—atherosclerosis	5.34e-06	8.04e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NOS3—atherosclerosis	5.33e-06	8.01e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTM1—atherosclerosis	5.2e-06	7.82e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—LPL—atherosclerosis	5.1e-06	7.67e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GPX1—atherosclerosis	4.98e-06	7.49e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PTGS2—atherosclerosis	4.87e-06	7.33e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CD36—atherosclerosis	4.85e-06	7.29e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.59e-06	6.91e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PPARA—atherosclerosis	4.51e-06	6.78e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—AGT—atherosclerosis	4.36e-06	6.57e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—APOE—atherosclerosis	4.28e-06	6.43e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CAV1—atherosclerosis	4.24e-06	6.37e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—APOA1—atherosclerosis	4.23e-06	6.36e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.86e-06	5.81e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PPARG—atherosclerosis	3.72e-06	5.6e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—INS—atherosclerosis	3.65e-06	5.5e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ALB—atherosclerosis	3.35e-06	5.04e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NOS3—atherosclerosis	3.2e-06	4.82e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—AKT1—atherosclerosis	3.17e-06	4.77e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.93e-06	4.41e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—AKT1—atherosclerosis	2.73e-06	4.1e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—AKT1—atherosclerosis	2.45e-06	3.68e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—AKT1—atherosclerosis	1.47e-06	2.22e-05	CbGpPWpGaD
